References

1. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, et al. (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186: 155-161 [CrossRef] [Google Scholar] [PubMed]
2. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, et al. (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6: 606-619 [CrossRef] [Google Scholar] [PubMed]
3. Cavaillès A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, et al. (2013) Comorbidities of COPD. Eur Respir Rev 22: 454-475 [CrossRef] [Google Scholar] [PubMed]
4. Clini EM, Boschetto P, Lainscak M, Janssens W (2014) Comorbidities in chronic obstructive pulmonary disease from assessment to treatment. Biomed Res Int 2014: 414928 [CrossRef] [Google Scholar]
5. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, et al. (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol 69: 1167 [CrossRef] [Google Scholar] [PubMed]
6. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, et al. (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10: 165-193 [CrossRef] [Google Scholar] [PubMed]
7. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, et al. (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355: 251-259 [CrossRef] [Google Scholar] [PubMed]
8. Fontes-Carvalho R, Ladeiras-Lopes R, Bettencourt P, Leite-Moreira A, Azevedo A, et al. (2015) Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes. Cardiovasc Diabetol 14: 4 [CrossRef] [Google Scholar] [PubMed]
9. Aslam F, Bandeali SJ, Khan NA, Alam M (2013) Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken) 65: 534-543 [CrossRef] [Google Scholar] [PubMed]
10. Redfield MM (2016) Heart Failure with Preserved Ejection Fraction. N Engl J Med 375: 1868-1877 [CrossRef] [PubMed]
11. Halley CM, Houghtaling PL, Khalil MK, Thomas JD, Jaber WA, et al. (2011) Mortality rate in patients with diastolic dysfunction and normal systolic function. Arch Intern Med 171: 1082-1087 [CrossRef] [Google Scholar] [PubMed]
12. Redfield MM, Jacobsen SJ, Burnett JC, Jr., Mahoney DW, Bailey KR, et al. (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289: 194-202 [CrossRef] [Google Scholar] [PubMed]
13. Ahmed A, Aronow WS, Fleg JL (2006) Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J 151: 444-450 [CrossRef] [Google Scholar] [PubMed]
14. Jones RC, Francis GS, Lauer MS (2004) Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 44: 1025-1029 [CrossRef] [Google Scholar] [PubMed]
15. Persson H, Lonn E, Edner M, Baruch L, Lang CC, et al. (2007) Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy- CHARMES. J Am Coll Cardiol 49: 687-694 [CrossRef] [Google Scholar] [PubMed]
16. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50: 40-47 [CrossRef] [Google Scholar] [PubMed]
17. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, et al. (2016) Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17: 1321-1360 [CrossRef] [Google Scholar] [PubMed]
18. AboEl-Magd Gehan HT, Aly Mohamed H., Mabrouk Maaly M (2017) Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricualr diastolic dysfunction in stable COPD in relation to disease severity. Egyptian Journal of Chest Diseases and Tuberculosis 66: 75-80 [CrossRef] [Google Scholar]
19. Acharya V RS, Seshaderi S, Shetty R (2018) Assessment of Diastolic Dysfunction Parameters and Cardiac Chamber Size in Smokers with COPD: A Case Control Study. Journal of Clinical and Diagnostic Research [CrossRef] [Google Scholar]
20. Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, et al. (2000) Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med 162: 670-675 [CrossRef] [Google Scholar] [PubMed]
21. Eweda I, Hamada G (2016) Concordance between Doppler and pulsedwave Doppler tissue imaging in estimation of the degree of left ventricular dysfunction and correlating it to the degree of chronic obstructive pulmonary disease. J Saudi Heart Assoc 28: 15-21 [CrossRef] [Google Scholar] [PubMed]
22. Faludi R, Hajdu M, Vertes V, et al. (2016) Diastolic Dysfunction Is a Contributing Factor to Exercise Intolerance in COPD. COPD 13: 345-351 [CrossRef] [Google Scholar] [PubMed]
23. Farouk H, Albasmi M, El Chilali K, et al. Left ventricular diastolic dysfunction in patients with chronic obstructive pulmonary disease: Impact of methods of assessment. Echocardiography 34: 359-364 [CrossRef] [Google Scholar] [PubMed]
24. Funk GC, Lang I, Schenk P, Valipour A, Hartl S, et al. (2008) Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest 133: 1354-1359 [CrossRef] [Google Scholar] [PubMed]
25. Huang YS, Feng YC, Zhang J, Bai L, Huang W, et al. (2015) Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients. Clin Interv Aging 10: 81-87 [CrossRef] [Google Scholar] [PubMed]
26. Kubota Y, Asai K, Murai K, Tsukada YT, Hayashi H, et al. (2016) COPD advances in left ventricular diastolic dysfunction. Int J Chron Obstruct Pulmon Dis 11: 649-655 [CrossRef] [Google Scholar] [PubMed]
27. Malerba M, Ragnoli B, Salameh M, Sennino G, Sorlini ML, et al. (2011) Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease. J Biol Regul Homeost Agents 25: 443-451 [Google Scholar] [PubMed]
28. Pelà G, Li Calzi M, Pinelli S, Andreoli R, Sverzellati N, et al. Left ventricular structure and remodeling in patients with COPD. Int J Chron Obstruct Pulmon Dis 11: 1015-1022 [CrossRef] [Google Scholar] [PubMed]
29. Sabit R, Bolton CE, Fraser AG, Edwards JM, Edwards PH, et al. (2010) Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med 104: 1171-1178 [CrossRef] [Google Scholar] [PubMed]
30. Suchoń E, Tracz W, Podolec P, Pieculewicz M, Płazak W, et al. (2007) [Evaluation of left ventricular function in patients with chronic obstructive pulmonary disease]. Pol Arch Med Wewn 117: 26-30 [Google Scholar] [PubMed]
31. El Wahsh RAA, Ahmed MK, Yassen RI (2013) Evaluation of Left ventricular function in patients with chronic obstructive pulmonary diease with or without pulmonary hypertension. Egyptian Journal of Chest Diseases and Tuberculosis 62: 575-582 [CrossRef]
32. Yilmaz R, Gencer M, Ceylan E, Demirbag R (2005) Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance. J Am Soc Echocardiogr 18: 873-881 [CrossRef] [Google Scholar] [PubMed]
33. Sin DD, Man SF (2005) Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2: 8-11 [CrossRef] [Google Scholar] [PubMed]
34. Finkelstein J, Cha E, Scharf SM (2009) Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 4: 337-349 [Google Scholar] [PubMed]
35. Gladden JD, Linke WA, Redfield MM (2014) Heart failure with preserved ejection fraction. Pflugers Arch 466: 1037-1053 [PubMed]
36. LeWinter MM, Meyer M (2013) Mechanisms of diastolic dysfunction in heart failure with a preserved ejection fraction: If it's not one thing it's another. Circ Heart Fail 6: 1112-1115 [CrossRef] [Google Scholar] [PubMed]
37. Fontes-Carvalho R, Leite-Moreira A (2011) Heart failure with preserved ejection fraction: fighting misconceptions for a new approach. Arq Bras Cardiol 96: 504-514 [CrossRef] [Google Scholar] [PubMed]
38. Biering-Sorensen T, Mogelvang R, Jensen JS (2015) Prognostic value of cardiac time intervals measured by tissue Doppler imaging M-mode in the general population. Heart 101: 954-960 [CrossRef] [Google Scholar] [PubMed]
39. Chhabra SK, De S (2005) Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease. Respir Med 99: 126-133 [CrossRef] [Google Scholar] [PubMed]
40. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, et al. (2010) Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 362: 217-227 [CrossRef] [Google Scholar]
41. Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, et al. (2010) Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 138: 32-38 [CrossRef] [Google Scholar] [PubMed]
42. Jorgensen K, Muller MF, Nel J, Upton RN, Houltz E, et al. (2007) Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 131: 1050-1057 [CrossRef] [Google Scholar] [PubMed]
43. Held M, Jany BH (2013) Pulmonary hypertension in COPD. Respir Care 58: 86-91
44. Barbera JA, Peinado VI, Santos S (2003) Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 21: 892-905 [CrossRef] [Google Scholar] [PubMed]
45. Chaouat A, Naeije R, Weitzenblum E (2008) Pulmonary hypertension in COPD. Eur Respir J 32: 1371-1385 [CrossRef] [Google Scholar] [PubMed]
46. Cargill RI, Kiely DG, Lipworth BJ (1995) Adverse effects of hypoxaemia on diastolic filling in humans. Clin Sci 89: 165-169 [CrossRef] [Google Scholar] [PubMed]
47. Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62: 263-271 [CrossRef] [Google Scholar] [PubMed]
48. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, et al. (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27: 2588-2605 [CrossRef] [Google Scholar] [PubMed]
49. Moustapha A, Kaushik V, Diaz S, Kang SH, Barasch E, et al. (2001) Echocardiographic evaluation of left-ventricular diastolic function in patients with chronic pulmonary hypertension. Cardiology 95: 96-100 [CrossRef] [Google Scholar] [PubMed]
50. Alpert JS (2001) The effect of right ventricular dysfunction on left ventricular form and function. Chest 119: 1632-1633 [CrossRef] [Google Scholar] [PubMed]
51. Tutar E, Kaya A, Güleç S, Ertaş F, Erol C, et al. (1999) Echocardiographic evaluation of left ventricular diastolic function in chronic cor pulmonale. Am J Cardiol 83: 1414-1417 [CrossRef] [Google Scholar] [PubMed]
52. Bhattacharyya P, Acharjee D, Ray SN, Sharma RK, Tiwari P, et al. (2012) Left ventricular diastolic dysfunction in COPD may manifest myocardial ischemia. COPD 9: 305-309 [CrossRef] [Google Scholar] [PubMed]
53. Holland DJ, Prasad SB, Marwick TH (2010) Prognostic implications of left ventricular filling pressure with exercise. Circ Cardiovasc Imaging 3: 149- 156 [CrossRef] [Google Scholar] [PubMed]